Your Account
EMSP’s External Affairs Director Christoph Thalheim outlined the three focus areas of the meeting:
- PCWP’s involvement summarising clinical trial results for laypersons.
- Patient involvement in benefit-risk evaluation
- Interaction guidance in the framework of the European Patients’ Academy on Therapeutic Innovation (EUPATI)
Christoph Thalheim made a special mention about the clinical trial results for laypersons, saying that once published they will be very important for EMSP members because they aim for a more patient-oriented language.
The meeting agenda can be found here.
More information on PCWP can be found here.
